# S.s.s. Company (international) – FDA 483, Jun 26, 2026

Source: https://www.keypedia.com/records/483/sss-company-international/b5d76fab-3d6c-46e9-a3bf-7e233cb79a31

> FDA 483 for S.s.s. Company (international) on June 26, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: S.s.s. Company (international)
- Inspection Date: 2026-06-26
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: S.S.S. Company (international) in Atlanta, GA, an OTC drug manufacturer, was cited for significant deficiencies across its quality system. The inspection revealed failures in recalling out-of-specification products, inadequate process and equipment validations, deficient component and laboratory controls, and a lack of adherence to stability testing programs. These issues indicate a systemic breakdown in ensuring drug product quality, strength, and purity.

## Related Officers

- [Steven D. Banks](https://www.keypedia.com/people/steven-d-banks/30e4d016-e386-423d-9df8-1536cf43a0a3)
- [Pharmaceutical Specialist/ Investigator ](https://www.keypedia.com/people/veronica-fuentes/50ea657f-39e6-4d97-a627-86339df3fbe6)
- [FDA_PERSONNEL](https://www.keypedia.com/people/lizaida-perez/686fbdca-bfd7-4a73-990a-d8a97e6b88b7)
- [Liralda Perez](https://www.keypedia.com/people/liralda-perez/bdad725e-1910-49fd-8fa7-1782ca211f38)

Company: https://www.keypedia.com/companies/sss-company-international/f322f704-186a-434c-83d2-9468fed1ae6e

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7